Medicare Program: Application by the Association of Diabetes Care and Education Specialists (ADCES) for Continued CMS Approval of Its Diabetes Outpatient Self-Management Training Program, 53660-53662 [2021-20957]

Download as PDF 53660 Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices testing, before travel into the United States; • Designated U.S. arrival Ports of Entry with specific testing operations and other services for Afghan Evacuees, which were specifically set up for early urgent evacuation arrival support, have been discontinued in the United States; and • Evacuees who are still outside of the United States are in safe locations where testing can be accessed before traveling. Authority: The CDC Director has issued this Notice authorizing the rescission of this temporary humanitarian exemption for individuals relocating to the United States from Afghanistan and reimposing the agency’s Requirement for Negative PreDeparture COVID–19 Test Result pursuant to Sections 361 of the Public Health Service Act, 42 U.S.C. 264, and implementing regulations at 42 CFR 71.20 and 71.31(b). This Notice is issued to inform the public of this action. Sherri Berger, Chief of Staff, Centers for Disease Control and Prevention. [FR Doc. 2021–20987 Filed 9–27–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3413–FN] Medicare Program: Application by the Association of Diabetes Care and Education Specialists (ADCES) for Continued CMS Approval of Its Diabetes Outpatient Self-Management Training Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Final notice. AGENCY: This final notice announces our decision to approve the Association of Diabetes Care and Education Specialists (ADCES) application for continued recognition as a national accrediting organization (AO) for accrediting entities that wish to furnish diabetes outpatient self-management training services to Medicare beneficiaries. SUMMARY: This final notice is effective on September 27, 2021 through September 27, 2027. FOR FURTHER INFORMATION CONTACT: Shannon Freeland, (410) 786–4348. Caroline Gallaher, (410) 786–8705. DATES: VerDate Sep<11>2014 16:35 Sep 27, 2021 Jkt 253001 Lillian Williams, (410) 786–8636. SUPPLEMENTARY INFORMATION: I. Background Diabetes outpatient self-management training services are defined in section 1861(qq)(1) of the Social Security Act (the Act) as ‘‘educational and training services furnished (at such times as the Secretary determines appropriate) to an individual with diabetes by a certified provider (as described in paragraph (2)(A)) in an outpatient setting by an individual or entity who meets the quality standards described in paragraph (2)(B), but only if the physician who is managing the individual’s diabetic condition certifies that such services are needed under a comprehensive plan of care related to the individual’s diabetic condition to ensure therapy compliance or to provide the individual with necessary skills and knowledge (including skills related to the self-administration of injectable drugs) to participate in the management of the individual’s condition.’’ In addition, section 1861(qq)(2)(A) of the Act describes a ‘‘certified provider’’ as a physician, or other individual or entity designated by the Secretary of the Department of Health and Human Services (the Secretary), that, in addition to providing diabetes outpatient self-management training services, provides other items or services for which payment may be made under this title. Section 1861(qq)(2)(B) of the Act further specifies that a physician, or such other individual or entity, must meet the quality standards established by the Secretary, except that the physician or other individual or entity shall be deemed to have met such standards if the physician or other individual or entity meets applicable standards originally established by the National Diabetes Advisory Board and subsequently revised by organizations who participated in the establishment of standards by such Board or is recognized by an organization that represents individuals (including individuals under this title) with diabetes as meeting standards for furnishing the services. Section 1865 of the Act also permits the Secretary to use accrediting bodies to determine whether a provider entity meets Medicare regulatory quality standards, such as those established for diabetes outpatient self-management training programs. These accrediting bodies determine whether a diabetes outpatient self-management training supplier meets the Medicare regulatory quality standards established for diabetes outpatient self-management PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 training service programs. A national accrediting organization (AO) must be approved by the Centers for Medicare & Medicaid Services (CMS) and meet the standards and requirements specified in 42 CFR part 410, subpart H, to qualify for Medicare deeming authority. Our regulations regarding the application procedures for diabetes outpatient self-management training AOs seeking CMS approval are set forth at 42 CFR 410.142. A national accreditation organization applying for deeming authority must provide CMS with reasonable assurance that it will require the diabetes outpatient selfmanagement training suppliers it accredits to meet the CMS’ quality standards, the National Standards for Diabetes Self-Management Education and Support (NSDSMES) standards, or an alternative set of standards that meet or exceed our requirements that have been developed by that AO and that have been approved by CMS (see 42 CFR 410.144). Section 410.142(a) of our regulations states that ‘‘CMS may approve and recognize a nonprofit organization with demonstrated experience in representing the interests of individuals with diabetes to accredit entities to furnish training.’’ Therefore, all diabetes outpatient self-management training AOs must be not-for-profit organizations. Section 410.142(b) of our regulations require a diabetes outpatient selfmanagement training AO to submit specific documents and information with their application, as discussed in section II of this final notice. II. Provisions of the Proposed Notice On April 27, 2021, we published a proposed notice in the Federal Register (86 FR 22208) acknowledging receipt of the Association of Diabetes Care and Education Specialists (ADCES) request for continued CMS approval of its diabetes outpatient self-management training accreditation program. In that proposed notice, we detailed our evaluation criteria. Under section 1861(qq) of the Act and our regulations at § 410.142, we conducted a review of the ADCES’s diabetes outpatient self-management training program application using the criteria specified by our regulations, which include authorization for CMS to conduct an onsite visit to verify information contained in the organization’s application. For an onsite visit, the CMS review team travels to the AO’s corporate office to review specific information and documents. An onsite visit is typically part of every application review. However, due to the E:\FR\FM\28SEN1.SGM 28SEN1 Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices COVID–19 pandemic, it was not possible for us to conduct an onsite visit for the ADCES. We conducted our review virtually, using remote means to access and review the necessary information. During this virtual review, we reviewed documentation including the ADECS’s: (1) Corporate policies; (2) financial and human resources records; (3) policies and procedures, including those for training, monitoring, and evaluation of its surveyors and investigating and responding appropriately to complaints against accredited diabetes outpatient selfmanagement training suppliers; and (4) survey review and decision-making process for accreditation. This is the same information that would have been reviewed during an onsite visit. Also, as part of our application review, we reviewed and assessed the following documents submitted by the ADCES: • A detailed comparison including a crosswalk between the organization’s standards and the CMS quality standards described in § 410.144(a). • Detailed information about the organization’s accreditation process, including all of the following information: ++ Frequency of accreditation. ++ Copies of accreditation forms, guidelines, and instructions to evaluators. ++ Descriptions of the following: —The accreditation review process and the accreditation status decision making process. —The procedures used to notify a deemed entity of deficiencies in its diabetes outpatient self-management training program and procedures to monitor the correction of those deficiencies. —The procedures used to enforce compliance with the accreditation requirements and standards. • Detailed information about the individuals who perform evaluations for the organization, including all of the following information: ++ The education and experience requirements for the individuals who perform evaluations. ++ The content and frequency of continuing education furnished to the individuals who perform evaluations. ++ The process used to monitor the performance of individuals who perform evaluations. ++ The organization’s policies and practices for participation in the accreditation process by an individual who is professionally or financially affiliated with the entity being evaluated. VerDate Sep<11>2014 16:35 Sep 27, 2021 Jkt 253001 • A description of the organization’s data management and analysis system for its accreditation activities and decisions, including the kinds of reports, tables, and other displays generated by that system. • A description of the organization’s procedures for responding to and investigating complaints against an approved entity, including policies and procedures regarding coordination of these activities with appropriate licensing bodies, ombudsmen programs, and CMS. • A description of the organization’s policies and procedures for withholding or removing a certificate of accreditation for failure to meet the organization’s standards or requirements, and other actions the organization takes in response to noncompliance with its standards and requirements. • A description of all types (for example, full or partial) and categories (for example, provisional, conditional, or temporary) of accreditation offered by the organization, the duration of each type and category of accreditation, and a statement identifying the types and categories that will serve as a basis for accreditation if CMS approves the organization. • A list of all of the approved entities currently accredited to furnish training and the type, category, and expiration date of the accreditation held by each of them. • The name and address of each person with an ownership or control interest in the organization. • Documentation that demonstrates its ability to furnish CMS with electronic data in CMS-compatible format. • A resource analysis that demonstrates that its staffing, funding, and other resources are adequate to perform the required accreditation activities. • A statement acknowledging that, as a condition for approval and recognition by CMS of its accreditation program, it agrees to comply with the requirements set forth in §§ 410.142 through 410.146. • Any additional information CMS requests to enable it to respond to the organization’s request for CMS approval and recognition of its accreditation program to accredit entities to furnish training. The April 27, 2021, proposed notice also solicited public comments regarding whether the ADCES’s requirements meet or exceed the NSDSMES, which are the accreditation standards used for certification of the diabetes outpatient self-management training programs accredited by the PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 53661 ADCES, pursuant to § 410.144(b) and § 410.142(e)(1). III. Analysis of and Responses to Public Comments on the Proposed Notice We received six public comments in response to the April 27, 2021 proposed notice; however, only one of these comments were within the scope of the comment solicitation. The comment and our response is addressed below. Comment: One commenter stated that diabetes outpatient self-management training is an evidence-based vital service for people with diagnosed diabetes and it has been proven that this service helps to enhance their clinical outcomes. The commenter further stated that it is imperative that the ADCES continue to offer its services as an AO for diabetes outpatient self-management training suppliers. Response: We thank the commenter for their support of the CMS diabetes outpatient self-management training program and for their recommendation that the ADCES continue as a CMSapproved diabetes outpatient selfmanagement training AO. IV. Provisions of the Final Notice A. Comparison of the ADCES’s Standards and Requirements for Accreditation to the NSDSMES and the Medicare Application Requirements We compared the ADCES’s diabetes outpatient self-management training accreditation requirements and survey process with the NSDSMES requirements, and the CMS application requirements in 42 CFR part 410, subpart H, as described in section II of this final notice. We found the ADCES accreditation standards and process to be consistent with the NSDSMES standards and the CMS requirements. B. Term of Approval Based on the review and observations described in section II of this final notice, we have determined that the ADCES’s requirements for diabetes outpatient self-management training meet our requirements. Therefore, we approve the ADCES as a national accreditation organization for diabetes outpatient self-management training programs that request participation in the Medicare program, effective September 27, 2021 through September 27, 2027. V. Collection of Information Requirements This document does not impose information collection requirements, that is, reporting, recordkeeping, or E:\FR\FM\28SEN1.SGM 28SEN1 53662 Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). The Administrator of the Centers for Medicare & Medicaid Services (CMS), Chiquita Brooks-LaSure, having reviewed and approved this document, authorizes Lynette Wilson, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. Dated: September 22, 2021. Lynette Wilson, Federal Register Liaison, Centers for Medicare & Medicaid Services. [FR Doc. 2021–20957 Filed 9–27–21; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–R–70, CMS–R– 72 and CMS–10783] Agency Information Collection Activities: Proposed Collection; Comment Request FOR FURTHER INFORMATION CONTACT: Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by November 29, 2021. SUMMARY: VerDate Sep<11>2014 16:35 Sep 27, 2021 Jkt 253001 When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number: llll, Room C4– 26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. ADDRESSES: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–R–70 Information Collection Requirements in HSQ–110, Acquisition, Protection and Disclosure of Peer review Organization Information and Supporting Regulations CMS–R–72 Information Collection Requirements in 42 CFR 478.18, 478.34, 478.36, 478.42, QIO Reconsiderations and Appeals CMS–10783 Generic Beneficiary and Family Centered-Care Quality Improvement Organization (BFCC–QIO) Data Collection Research Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Information Collection Requirements in HSQ–110, Acquisition, Protection and Disclosure of Peer review Organization Information and Supporting Regulations; Use: The Peer Review Improvement Act of 1982 authorizes quality improvement organizations (QIOs), formally known as peer review organizations (PROs), to acquire information necessary to fulfill their duties and functions and places limits on disclosure of the information. The QIOs are required to provide notices to the affected parties when disclosing information about them. These requirements serve to protect the rights of the affected parties. The information provided in these notices is used by the patients, practitioners and providers to: Obtain access to the data maintained and collected on them by the QIOs; add additional data or make changes to existing QIO data; and reflect in the QIO’s record the reasons for the QIO’s disagreeing with an individual’s or provider’s request for amendment. Form Number: CMS–R–70 (OMB control number: 0938–0426); Frequency: Reporting—On occasion; Affected Public: Business or other for-profits; Number of Respondents: 53,850; Total Annual Responses: 436,984; Total Annual Hours: 404,208. (For policy questions regarding this collection contact Kimberly Harris at 617–565– 1285.) 2. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Information Collection Requirements in 42 CFR 478.18, 478.34, 478.36, 478.42, QIO Reconsiderations and Appeals; Use: In the event that a beneficiary, provider, physician, or other practitioner does not agree with the initial determination of a Quality Improvement Organization (QIO) or a QIO subcontractor, it is within that party’s rights to request E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Pages 53660-53662]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20957]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3413-FN]


Medicare Program: Application by the Association of Diabetes Care 
and Education Specialists (ADCES) for Continued CMS Approval of Its 
Diabetes Outpatient Self-Management Training Program

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final notice.

-----------------------------------------------------------------------

SUMMARY: This final notice announces our decision to approve the 
Association of Diabetes Care and Education Specialists (ADCES) 
application for continued recognition as a national accrediting 
organization (AO) for accrediting entities that wish to furnish 
diabetes outpatient self-management training services to Medicare 
beneficiaries.

DATES: This final notice is effective on September 27, 2021 through 
September 27, 2027.

FOR FURTHER INFORMATION CONTACT: 
Shannon Freeland, (410) 786-4348.
Caroline Gallaher, (410) 786-8705.
Lillian Williams, (410) 786-8636.

SUPPLEMENTARY INFORMATION:

I. Background

    Diabetes outpatient self-management training services are defined 
in section 1861(qq)(1) of the Social Security Act (the Act) as 
``educational and training services furnished (at such times as the 
Secretary determines appropriate) to an individual with diabetes by a 
certified provider (as described in paragraph (2)(A)) in an outpatient 
setting by an individual or entity who meets the quality standards 
described in paragraph (2)(B), but only if the physician who is 
managing the individual's diabetic condition certifies that such 
services are needed under a comprehensive plan of care related to the 
individual's diabetic condition to ensure therapy compliance or to 
provide the individual with necessary skills and knowledge (including 
skills related to the self-administration of injectable drugs) to 
participate in the management of the individual's condition.''
    In addition, section 1861(qq)(2)(A) of the Act describes a 
``certified provider'' as a physician, or other individual or entity 
designated by the Secretary of the Department of Health and Human 
Services (the Secretary), that, in addition to providing diabetes 
outpatient self-management training services, provides other items or 
services for which payment may be made under this title. Section 
1861(qq)(2)(B) of the Act further specifies that a physician, or such 
other individual or entity, must meet the quality standards established 
by the Secretary, except that the physician or other individual or 
entity shall be deemed to have met such standards if the physician or 
other individual or entity meets applicable standards originally 
established by the National Diabetes Advisory Board and subsequently 
revised by organizations who participated in the establishment of 
standards by such Board or is recognized by an organization that 
represents individuals (including individuals under this title) with 
diabetes as meeting standards for furnishing the services.
    Section 1865 of the Act also permits the Secretary to use 
accrediting bodies to determine whether a provider entity meets 
Medicare regulatory quality standards, such as those established for 
diabetes outpatient self-management training programs. These 
accrediting bodies determine whether a diabetes outpatient self-
management training supplier meets the Medicare regulatory quality 
standards established for diabetes outpatient self-management training 
service programs. A national accrediting organization (AO) must be 
approved by the Centers for Medicare & Medicaid Services (CMS) and meet 
the standards and requirements specified in 42 CFR part 410, subpart H, 
to qualify for Medicare deeming authority.
    Our regulations regarding the application procedures for diabetes 
outpatient self-management training AOs seeking CMS approval are set 
forth at 42 CFR 410.142. A national accreditation organization applying 
for deeming authority must provide CMS with reasonable assurance that 
it will require the diabetes outpatient self-management training 
suppliers it accredits to meet the CMS' quality standards, the National 
Standards for Diabetes Self-Management Education and Support (NSDSMES) 
standards, or an alternative set of standards that meet or exceed our 
requirements that have been developed by that AO and that have been 
approved by CMS (see 42 CFR 410.144).
    Section 410.142(a) of our regulations states that ``CMS may approve 
and recognize a nonprofit organization with demonstrated experience in 
representing the interests of individuals with diabetes to accredit 
entities to furnish training.'' Therefore, all diabetes outpatient 
self-management training AOs must be not-for-profit organizations.
    Section 410.142(b) of our regulations require a diabetes outpatient 
self-management training AO to submit specific documents and 
information with their application, as discussed in section II of this 
final notice.

II. Provisions of the Proposed Notice

    On April 27, 2021, we published a proposed notice in the Federal 
Register (86 FR 22208) acknowledging receipt of the Association of 
Diabetes Care and Education Specialists (ADCES) request for continued 
CMS approval of its diabetes outpatient self-management training 
accreditation program. In that proposed notice, we detailed our 
evaluation criteria.
    Under section 1861(qq) of the Act and our regulations at Sec.  
410.142, we conducted a review of the ADCES's diabetes outpatient self-
management training program application using the criteria specified by 
our regulations, which include authorization for CMS to conduct an 
onsite visit to verify information contained in the organization's 
application. For an onsite visit, the CMS review team travels to the 
AO's corporate office to review specific information and documents. An 
onsite visit is typically part of every application review. However, 
due to the

[[Page 53661]]

COVID-19 pandemic, it was not possible for us to conduct an onsite 
visit for the ADCES. We conducted our review virtually, using remote 
means to access and review the necessary information. During this 
virtual review, we reviewed documentation including the ADECS's: (1) 
Corporate policies; (2) financial and human resources records; (3) 
policies and procedures, including those for training, monitoring, and 
evaluation of its surveyors and investigating and responding 
appropriately to complaints against accredited diabetes outpatient 
self-management training suppliers; and (4) survey review and decision-
making process for accreditation. This is the same information that 
would have been reviewed during an onsite visit.
    Also, as part of our application review, we reviewed and assessed 
the following documents submitted by the ADCES:
     A detailed comparison including a crosswalk between the 
organization's standards and the CMS quality standards described in 
Sec.  410.144(a).
     Detailed information about the organization's 
accreditation process, including all of the following information:
    ++ Frequency of accreditation.
    ++ Copies of accreditation forms, guidelines, and instructions to 
evaluators.
    ++ Descriptions of the following:
    --The accreditation review process and the accreditation status 
decision making process.
    --The procedures used to notify a deemed entity of deficiencies in 
its diabetes outpatient self-management training program and procedures 
to monitor the correction of those deficiencies.
    --The procedures used to enforce compliance with the accreditation 
requirements and standards.
     Detailed information about the individuals who perform 
evaluations for the organization, including all of the following 
information:
    ++ The education and experience requirements for the individuals 
who perform evaluations.
    ++ The content and frequency of continuing education furnished to 
the individuals who perform evaluations.
    ++ The process used to monitor the performance of individuals who 
perform evaluations.
    ++ The organization's policies and practices for participation in 
the accreditation process by an individual who is professionally or 
financially affiliated with the entity being evaluated.
     A description of the organization's data management and 
analysis system for its accreditation activities and decisions, 
including the kinds of reports, tables, and other displays generated by 
that system.
     A description of the organization's procedures for 
responding to and investigating complaints against an approved entity, 
including policies and procedures regarding coordination of these 
activities with appropriate licensing bodies, ombudsmen programs, and 
CMS.
     A description of the organization's policies and 
procedures for withholding or removing a certificate of accreditation 
for failure to meet the organization's standards or requirements, and 
other actions the organization takes in response to noncompliance with 
its standards and requirements.
     A description of all types (for example, full or partial) 
and categories (for example, provisional, conditional, or temporary) of 
accreditation offered by the organization, the duration of each type 
and category of accreditation, and a statement identifying the types 
and categories that will serve as a basis for accreditation if CMS 
approves the organization.
     A list of all of the approved entities currently 
accredited to furnish training and the type, category, and expiration 
date of the accreditation held by each of them.
     The name and address of each person with an ownership or 
control interest in the organization.
     Documentation that demonstrates its ability to furnish CMS 
with electronic data in CMS-compatible format.
     A resource analysis that demonstrates that its staffing, 
funding, and other resources are adequate to perform the required 
accreditation activities.
     A statement acknowledging that, as a condition for 
approval and recognition by CMS of its accreditation program, it agrees 
to comply with the requirements set forth in Sec. Sec.  410.142 through 
410.146.
     Any additional information CMS requests to enable it to 
respond to the organization's request for CMS approval and recognition 
of its accreditation program to accredit entities to furnish training.
    The April 27, 2021, proposed notice also solicited public comments 
regarding whether the ADCES's requirements meet or exceed the NSDSMES, 
which are the accreditation standards used for certification of the 
diabetes outpatient self-management training programs accredited by the 
ADCES, pursuant to Sec.  410.144(b) and Sec.  410.142(e)(1).

III. Analysis of and Responses to Public Comments on the Proposed 
Notice

    We received six public comments in response to the April 27, 2021 
proposed notice; however, only one of these comments were within the 
scope of the comment solicitation.
    The comment and our response is addressed below.
    Comment: One commenter stated that diabetes outpatient self-
management training is an evidence-based vital service for people with 
diagnosed diabetes and it has been proven that this service helps to 
enhance their clinical outcomes. The commenter further stated that it 
is imperative that the ADCES continue to offer its services as an AO 
for diabetes outpatient self-management training suppliers.
    Response: We thank the commenter for their support of the CMS 
diabetes outpatient self-management training program and for their 
recommendation that the ADCES continue as a CMS-approved diabetes 
outpatient self-management training AO.

IV. Provisions of the Final Notice

A. Comparison of the ADCES's Standards and Requirements for 
Accreditation to the NSDSMES and the Medicare Application Requirements

    We compared the ADCES's diabetes outpatient self-management 
training accreditation requirements and survey process with the NSDSMES 
requirements, and the CMS application requirements in 42 CFR part 410, 
subpart H, as described in section II of this final notice.
    We found the ADCES accreditation standards and process to be 
consistent with the NSDSMES standards and the CMS requirements.

B. Term of Approval

    Based on the review and observations described in section II of 
this final notice, we have determined that the ADCES's requirements for 
diabetes outpatient self-management training meet our requirements. 
Therefore, we approve the ADCES as a national accreditation 
organization for diabetes outpatient self-management training programs 
that request participation in the Medicare program, effective September 
27, 2021 through September 27, 2027.

V. Collection of Information Requirements

    This document does not impose information collection requirements, 
that is, reporting, recordkeeping, or

[[Page 53662]]

third-party disclosure requirements. Consequently, there is no need for 
review by the Office of Management and Budget under the authority of 
the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.).
    The Administrator of the Centers for Medicare & Medicaid Services 
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this 
document, authorizes Lynette Wilson, who is the Federal Register 
Liaison, to electronically sign this document for purposes of 
publication in the Federal Register.

    Dated: September 22, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2021-20957 Filed 9-27-21; 8:45 am]
BILLING CODE 4120-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.